24 June 2020 - Congress must act now to ensure that COVID-19 vaccines and treatments are affordable.
Since the start of the race for a COVID-19 vaccine, the U.S. government has funnelled more than $10 billion in taxpayer dollars to pharmaceutical companies through contracts for the expedited innovation of a vaccine.
So far, the government’s investment has been made with no strings attached, not even a guarantee that any vaccines and treatments will be affordable to the people who need them.